A Eckardt
4 Papers
13 Citations
A Eckardt is an academic researcher. The author has contributed to research in topics: Cathepsin & Osteolysis. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
•Journal Article
Cathepsin K in aseptic hip prosthesis loosening: expression in osteoclasts without polyethylene wear particles.
Torsten Hansen,M. Otto,A. Gaumann,A Eckardt,P.K. Petrow,K S Delank,Charles James Kirkpatrick,J. Kriegsmann +7 more
TL;DR: The present data suggest that in AHPL neither mononuclear cells nor MGC but rather osteoclasts are mainly involved in cathepsin K mediated bone matrix destruction.
10
Immunhistochemische Analyse periprothetischer Osteolysen aseptischer Hüftprothesenlockerungen
S. Gravius,Torsten Mumme,Karl-Stefan Delank,A Eckardt,U. Maus,Stefan Andereya,Torsten Hansen +6 more
TL;DR: In this paper, the authors performed immunohistochemical analysis on 14 patients with failed modular cup components of total hip arthroplasties during revision surgery and found that the majority of cells were of the mononuclear phagocyte system (MPS), which is involved in osteolytic processes.
6
Infections of the musculoskeletal system with chronic polyarthritis during a combination therapy with Methotrexate and Leflunomide
TL;DR: The observation of three serious infections under the combination MTX/Leflunomide prompted us to call attention to this risk, and with infection-susceptible bone-surgical operations such a combination of immune-modulating medicines should be employed with caution.
•Journal Article
Cathepsin B and its endogenous inhibitor cystatin C in rheumatoid arthritis synovium.
TL;DR: The strong expression of both the matrix degrading cysteine proteinase cathepsin B and the cystein proteinase inhibitor cystatin C in rheumatoid synovium, particularly at the sites of bone and cartilage erosion, suggests that cyStatin C--although increased--is not sufficient to prevent matrix degradation by cathePSin B.